Robert M. Davis

Rob Davis is an accomplished executive who currently serves as the chairman of the board and chief executive officer (CEO) of Merck, a leading global pharmaceutical company. With a diverse background in finance, operations, and leadership, Davis has played a pivotal role in shaping Merck's success.

Prior to his current position, Davis held several key roles within Merck. He served as the president, overseeing the company's operating divisions, including Human Health, Animal Health, Manufacturing, and Merck Research Laboratories. Before that, he held the position of executive vice president of Global Services and served as the company's chief financial officer (CFO).

Davis joined Merck in 2014 as the CFO and was entrusted with additional responsibilities such as real estate operations, corporate strategy, and business development. In 2016, he expanded his role to include information technology and procurement, establishing the Global Services division. In recognition of his leadership and contributions, Davis was appointed president in April 2021 and assumed the role of CEO and board member on July 1, 2021. He further ascended to the position of chairman of the board on December 1, 2022.

Before joining Merck, Davis held prominent positions at Baxter, a global healthcare company. His roles at Baxter included corporate vice president and president of the medical products business, president of the renal business, CFO, and treasurer. Prior to his tenure at Baxter, Davis spent 14 years at Eli Lilly and Company, where he held various positions of increasing responsibility.

Beyond his commitments at Merck, Davis serves on the board of directors for Duke Energy Corporation, one of the largest energy-holding companies in the United States. Within Duke Energy, he chairs the finance and risk management committee and contributes to the corporate governance committee. Additionally, he is a board member of Project Hope, a nonprofit organization focused on empowering healthcare workers to deliver expert care globally. Davis also serves as a board member of Catalyst, a global nonprofit promoting equal access to career opportunities and leadership for women.

Davis earned his J.D. from Northwestern University School of Law and holds an M.B.A. from Northwestern University's Kellogg Graduate School of Management. He obtained his bachelor's degree in finance from Miami University. With his extensive experience and multidimensional expertise, Davis continues to make significant contributions to the healthcare and pharmaceutical industry, driving Merck's growth and advancing the company's mission to improve human health worldwide.

Rob Davis is a highly accomplished executive with extensive experience in the healthcare and pharmaceutical industry. He currently serves as the Chairman and Chief Executive Officer (CEO) of Merck, a global pharmaceutical company.

Davis began his career at Merck in 2014 when he joined as the Chief Financial Officer (CFO). In this role, he was responsible for overseeing the company's financial operations, real estate operations, corporate strategy, and business development. Over time, his role expanded to include additional responsibilities such as information technology and procurement, forming the Global Services division. In April 2021, Davis was appointed as the President of Merck, overseeing the company's operating divisions, including Human Health, Animal Health, Manufacturing, and Merck Research Laboratories. He assumed the role of CEO and became a member of the board of directors on July 1, 2021. Later, in December 2022, he was appointed as the Chairman of the board.

Before joining Merck, Davis held various leadership positions at Baxter, a global healthcare company. He served as the Corporate Vice President and President of Baxter's medical products business, where he played a crucial role in driving business growth and success. Additionally, he held positions such as President of Baxter's renal business, CFO, and Treasurer. Prior to his tenure at Baxter, Davis spent 14 years at Eli Lilly and Company, where he held positions of increasing responsibility, including Director of Corporate Financial Planning.

Apart from his role at Merck, Davis serves on the board of directors for Duke Energy Corporation, one of the largest energy-holding companies in the United States. He chairs the finance and risk management committee within Duke Energy and contributes to the corporate governance committee. Davis is also a board member of Project Hope, a nonprofit organization focused on empowering healthcare workers, and Catalyst, a global nonprofit promoting equal access to career opportunities and leadership for women.

Davis earned his J.D. from Northwestern University School of Law and holds an M.B.A. from Northwestern University's Kellogg Graduate School of Management. He completed his bachelor's degree in finance from Miami University.

Rob Davis, as the Chairman and Chief Executive Officer of Merck, embodies a strong vision for the company's future. With his extensive experience and leadership skills, he is dedicated to driving Merck towards continued growth and success in the healthcare industry.

Rob's vision revolves around advancing healthcare and improving the lives of patients worldwide. He recognizes the vital role that Merck plays in developing innovative solutions and therapies to address unmet medical needs. Under his guidance, the company strives to make significant contributions to healthcare by focusing on research, development, and commercialization of breakthrough medicines and vaccines.

In line with his vision, Rob Davis emphasizes the importance of collaboration and partnerships. He seeks to foster strong relationships with healthcare providers, regulators, and other stakeholders to create a collective effort in addressing global health challenges. By working together, he believes that Merck can make a meaningful impact and shape the future of healthcare.

Furthermore, Rob is committed to maintaining Merck's reputation as a responsible and ethical company. He places a strong emphasis on integrity, transparency, and ethical business practices. He envisions Merck as a leader in corporate social responsibility, striving to positively impact society and the environment.

Rob Davis's vision extends beyond the immediate goals of Merck. He recognizes the evolving landscape of healthcare and the increasing importance of digital innovation. He aims to position Merck at the forefront of the digital revolution, leveraging technology to enhance patient outcomes, improve healthcare delivery, and drive operational efficiency.